Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein

Biology of Reproduction

Volumn 85, Issue 6, 2011, Pages 1133-1142

  Déry, Marie Claude ^a   Chaudhry, Parvesh ^a   Leblanc, Valérie ^a   Parent, Sophie ^a   Fortier, Anne Marie ^a   Asselin, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Cancer; Cell culture; Endometrium; Invasion; Mmp14; Mmp2; Oxytocin; Ptgs1; Ptgs2; Xiap

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE A; MATRIX METALLOPROTEINASE 14; OXYTOCIN; OXYTOCIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA INTERFERENCE; UPREGULATION;

CARCINOMA; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; FEMALE; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; OXYTOCIN; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, OXYTOCIN; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84855408634     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.093278     Document Type: Article

References (53)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
2. Holland JF, Frei E III. Endometrial cancer. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E III (eds.), Cancer Medicine, 7th ed., Hamilton, Ontario: BC Decker; 2006: 1522-1538.
3. Silverman AJ, Zimmerman EA. Magnocellular neurosecretory system. Annu Rev Neurosci 1983; 6:357-380.
4. Cassoni P, Marrocco T, Deaglio S, Sapino A, Bussolati G. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors. Ann Oncol 2001; 12(suppl 2):S37-S39.
5. Cassoni P, Sapino A, Marrocco T, Chini B, Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J Neuroendocrinol 2004; 16:362-364.
6. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature 1992; 356:526-529.
7. Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab 2003; 14:222-227.
8. Bussolati G, Cassoni P. Editorial: the oxytocin/oxytocin receptor system- expect the unexpected. Endocrinology 2001; 142:1377-1379.
9. Asselin E, Goff AK, Bergeron H, Fortier MA. Influence of sex steroids on the production of prostaglandins F2 alpha and E2 and response to oxytocin in cultured epithelial and stromal cells of the bovine endometrium. Biol Reprod 1996; 54:371-379.
10. Tithof PK, Roberts MP, Guan W, Elgayyar M, Godkin JD. Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2alpha production by bovine endometrial epithelial cells. Reprod Biol Endocrinol 2007; 5:16.
11. Copland JA, Jeng YJ, Strakova Z, Ives KL, Hellmich MR, Soloff MS. Demonstration of functional oxytocin receptors in human breast Hs578T cells and their up-regulation through a protein kinase C-dependent pathway. Endocrinology 1999; 140:2258-2267.
12. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30:377-386.
13. Kennedy TG. Prostaglandins and uterine sensitization for the decidual cell reaction. Ann N Y Acad Sci 1986; 476:43-48.
14. Wu WK, Yiu Sung JJ, Lee CW, Yu J, Cho CH. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 2010; 295:7-16.
15. Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S, Bussolati G. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. J Pathol 2000; 190:470-477.
16. Cassoni P, Marrocco T, Bussolati B, Allia E, Munaron L, Sapino A, Bussolati G. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumorderived endothelial cells. Mol Cancer Res 2006; 4:351-359.
17. Cattaneo MG, Chini B, Vicentini LM. Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol 2008; 153:728-736.
18. Narko K, Ristimaki A, MacPhee M, Smith E, Haudenschild CC, Hla T. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J Biol Chem 1997; 272:21455-21460.
19. Ohno S, Ohno Y, Suzuki N, Inagawa H, Kohchi C, Soma G, Inoue M. Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res 2005; 25:3679-3687.
20. Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC, Paraskeva C. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis 2009; 30:1796-1804.
21. Sexton E, Van Themsche C, Leblanc K, Parent S, Lemoine P, Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 2006; 5:45.
22. St Germain ME, Gagnon V, Parent S, Asselin E. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol Cancer 2004; 3:7.
23. St Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 2004; 24:1311-1324.
24. Amir M, Agarwal HK. Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 2005; 60:563-570.
25. Gao J, Mazella J, Tang M, Tseng L. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells. Mol Endocrinol 2000; 14:1954-1961.
26. Van Themsche C, Mathieu I, Parent S, Asselin E. Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of Xlinked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metalloproteinase-9. J Biol Chem 2007; 282:4794-4802.
27. Zhang Z, Song T, Jin Y, Pan J, Zhang L, Wang L, Li P. Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways. Int J Gynecol Cancer 2009; 19:998-1003.
28. Blanks AM, Thornton S. The role of oxytocin in parturition. BJOG 2003; 110(suppl 20):46-51.
29. Chandrasekher YA, Fortune JE. Effects of oxytocin on steroidogenesis by bovine theca and granulosa cells. Endocrinology 1990; 127:926-933.
30. Einspanier A, Ivell R, Hodges JK. Oxytocin: a follicular luteinisation factor in the marmoset monkey. Adv Exp Med Biol 1995; 395:517-522.
31. Einspanier A, Jurdzinski A, Hodges JK. A local oxytocin system is part of the luteinization process in the preovulatory follicle of the marmoset monkey (Callithrix jacchus). Biol Reprod 1997; 57:16-26.
32. Flint AP, Lamming GE, Stewart HJ, Abayasekara DR. The role of the endometrial oxytocin receptor in determining the length of the sterile oestrous cycle and ensuring maintenance of luteal function in early pregnancy in ruminants. Philos Trans R Soc Lond B Biol Sci 1994; 344:291-304.
33. Kiss A, Mikkelsen JD. Oxytocin-anatomy and functional assignments: a minireview. Endocr Regul 2005; 39:97-105.
34. Frayne J, Nicholson HD. Localization of oxytocin receptors in the human and macaque monkey male reproductive tracts: evidence for a physiological role of oxytocin in the male. Mol Hum Reprod 1998; 4:527-532.
35. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81:629-683.
36. Ivell R, Balvers M, Rust W, Bathgate R, Einspanier A. Oxytocin and male reproductive function. Adv Exp Med Biol 1997; 424:253-264.
37. Jankowski M, Hajjar F, Kawas SA, Mukaddam-Daher S, Hoffman G, McCann SM, Gutkowska J. Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A 1998; 95:14558-14563.
38. Lefebvre DL, Giaid A, Bennett H, Lariviere R, Zingg HH. Oxytocin gene expression in rat uterus. Science 1992; 256:1553-1555.
39. Lefebvre DL, Giaid A, Zingg HH. Expression of the oxytocin gene in rat placenta. Endocrinology 1992; 130:1185-1192.
40. Cassoni P, Sapino A, Negro F, Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch 1994; 425:467-472.
41. Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer 1997; 72:340-344.
42. Cassoni P, Sapino A, Stella A, Bussolati G. Antiproliferative effect of oxytocin through specific oxytocin receptors in human neuroblastoma and astrocytoma cell lines. Adv Exp Med Biol 1998; 449:245-246.
43. Cassoni P, Sapino A, Stella A, Fortunati N, Bussolati G. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. Int J Cancer 1998; 77:695-700.
44. Cassoni P, Sapino A, Munaron L, Deaglio S, Chini B, Graziani A, Ahmed A, Bussolati G. Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines. Endocrinology 2001; 142:1130-1136.
45. Morita T, Shibata K, Kikkawa F, Kajiyama H, Ino K, Mizutani S. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. Int J Cancer 2004; 109:525-532.
46. Van Themsche C, Lafontaine L, Asselin E. X-linked inhibitor of apoptosis protein levels and protein kinase C activity regulate the sensitivity of human endometrial carcinoma cells to tumor necrosis factor alpha-induced apoptosis. Endocrinology 2008; 149:3789-3798.
47. Parent J, Villeneuve C, Fortier MA. Evaluation of the contribution of cyclooxygenase 1 and cyclooxygenase 2 to the production of PGE2 and PGF2 alpha in epithelial cells from bovine endometrium. Reproduction 2003; 126:539-547.
48. Lee EJ, Choi EM, Kim SR, Park JH, Kim H, Ha KS, Kim YM, Kim SS, Choe M, Kim JI, Han JA. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Exp Mol Med 2007; 39:469-476.
49. Mignon C, Okada A, Mattei MG, Basset P. Assignment of the human membrane-type matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization. Genomics 1995; 28:360-361.
50. Lau MT, Wong AS, Leung PC. Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells. Endocrinology 2010; 151:2985-2993.
51. Xiao CW, Ash K, Tsang BK. Nuclear factor-kappaB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis. Endocrinology 2001; 142:557-563.
52. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388:300-304.
53. Fuchs AR, Fuchs F, Soloff MS. Oxytocin receptors in nonpregnant human uterus. J Clin Endocrinol Metab 1985; 60:37-41.